AUBELPHARMA
ActiveAUBELPHARMA has been active since 1989 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €111k and a net result of €103k. Equity is growing by ~3.6% per year across the filed fiscal years. Its solvency ranks better than 26% of 4137 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.4% (very low).
Checked score
Score 2025
72
/ 100
Healthy
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability87▼-1
Solvency41▼-1
Growth78=
Track record100
Bankruptcy probability, 12 months
0.4%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €7k at 30 days acceptable
Liquidity tight (current ratio 1.33 against 1.36 in 2024; short-term debt: 56.5% and cash: 41.6% of total assets), and 84.1% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Eight signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Sector 47
higher
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
15.9%
Return on assets
14.8%
Age of the figures
9 mo
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 14-08-2026, 14 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filingsDeviation from the deadline
2025
14 d late
2024
29 d late
2023
30 d late
2022
30 d late
2021
30 d late
2020
30 d late
2019
54 d late
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
18-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, full schema
Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
€103k▲ 0.2%
2024 · €103k
2018: €74k
2019: €61k
2020: €106k
2021: €90k
2022: €129k
2023: €120k
2024: €103k
2018 → 2025
Working capital
€129k▲ 5.9%
2024 · €122k
2018: €104k
2019: €116k
2020: €130k
2021: €182k
2022: €225k
2023: €129k
2024: €122k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€92k-€110k▲ 18.9%€110k▲ 0.4%€110k▲ 0.2%€111k▲ 0.1%
Operating result€101k-€147k▲ 45.1%€134k▼ 8.9%€135k▲ 0.8%€127k▼ 6.0%
Net result€90k-€129k▲ 43.9%€120k▼ 6.6%€103k▼ 14.3%€103k▲ 0.2%
Result per fiscal year
Operating resultNet result
The operating result falls in 2025; 2025 is 6% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €697k
Fixed assets
€175k▼ 13.3%
Current assets
€522k▲ 14.3%
Equity and liabilities €697k
Equity
€111k▲ 0.1%
Debt
€586k▲ 7.0%
The debt ratio rises from 83.2% to 84.1%. Equity and debt are higher.
Key figures and ratios
EBITDA
€153k▼
2024 · €162k
Cash flow
€130k=
2024 · €130k
Solvency
15.9%▼
2024 · 16.8%
Current ratio
1.33▼
2024 · 1.36
Quick ratio
0.96▲
2024 · 0.86
Debt / equity
5.30▲
2024 · 4.96
ROE
93.6%▲
2024 · 93.5%
ROA
14.8%▼
2024 · 15.7%
Interest coverage
14.02▼
2024 · 14.11
Debt
€586k▲
2024 · €548k
Debt ≤ 1 year
€394k▲
2024 · €335k
Debt > 1 year
€176k▼
2024 · €201k
Income taxes
€12k▼
2024 · €20k
Staff costs
€60k▲
2024 · €54k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€658k€697k▲
Fixed assets21/28€201k€175k▼
Tangible fixed assets22/27€201k€175k▼
Land and buildings22€183k€162k▼
Plant, machinery and equipment23€17k€13k▼
Furniture and vehicles24€1k€0▼
Current assets29/58€457k€522k▲
Stocks and contracts in progress3€169k€146k▼
Stocks30/36€169k€146k▼
Amounts receivable within one year40/41€74k€87k▲
Trade receivables40€69k€76k▲
Other amounts receivable41€5k€11k▲
Cash at bank and in hand54/58€213k€290k▲
Deferred charges and accrued income490/1€372€73▼
Equity and liabilities
Total equity and liabilities10/49€658k€697k▲
Equity10/15€110k€111k▲
Contributions10/11€62k€62k=
Capital10€62k€62k=
Issued capital100€62k€62k=
Reserves13€48k€49k▲
Non-distributable reserves130/1€6k€6k=
Legal reserve130€6k€6k=
Distributable reserves133€42k€42k▲
Profit (loss) carried forward14€0€0=
Amounts payable17/49€548k€586k▲
Amounts payable after more than one year17€201k€176k▼
Financial debts170/4€201k€176k▼
Amounts payable within one year42/48€335k€394k▲
Current portion of amounts payable after more than one year42€24k€25k▲
Trade debts44€34k€31k▼
Suppliers440/4€34k€31k▼
Taxes, remuneration and social security45€11k€10k▼
Taxes450/3€3k€384▼
Remuneration and social security454/9€9k€9k▲
Other amounts payable47/48€265k€328k▲
Accrued charges and deferred income492/3€12k€17k▲
Income statement
Code20242025
Remuneration, social security and pensions62€54k€60k▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€27k€27k▼
Other operating charges640/8€3k€3k▲
Gross operating margin9900€219k€216k▼
Operating profit (loss)9901€135k€127k▼
Financial income75/76B€66€96▲
Recurring financial income75€66€96▲
Financial charges65/66B€11k€11k▼
Recurring financial charges65€11k€11k▼
Profit (loss) for the period before taxes9903€123k€116k▼
Income taxes67/77€20k€12k▼
Profit (loss) for the period9904€103k€103k▲
Profit (loss) for the period to be appropriated9905€103k€103k▲
Appropriation of the result
Profit (loss) to be appropriated9906€103k€103k▲
Transfer to equity691/2€272€67▼
To other reserves6921€272€67▼
Profit to be distributed694/7€103k€103k▲
Return on contributions (dividend)694€58k€33k▼
Directors or managers695€45k€70k▲
Social balance
Average headcount (FTE)90871.01.0=
The notes to these accounts (11 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
14-08
NBB filing
Annual accounts filed
fiscal year 2025 · full schema · 14 days late
2025
29-08
NBB filing
Annual accounts filed
fiscal year 2024 · full schema · 29 days late
2024
30-08
NBB filing
Annual accounts filed
fiscal year 2023 · full schema · 30 days late
2023
30-08
NBB filing
Annual accounts filed
fiscal year 2022 · full schema · 30 days late
2022
31-12
Financial
Highest result since 2018net €129k ▲43.9%
Operating result €147k, net result €129k, both a record.
31-12
Financial
Equity above €100kEq €110k ▲18.9%
5 profitable years in a row build equity to €110k.
30-08
NBB filing
Annual accounts filed
fiscal year 2021 · full schema · 30 days late
2021
30-08
NBB filing
Annual accounts filed
fiscal year 2020 · full schema · 30 days late
2020
23-09
NBB filing
Annual accounts filed
fiscal year 2019 · full schema · 54 days late
2019
31-12
Financial
Weakest financial yearnet €61k ▼17.4%
Net result drops to €61k, the lowest in the series; recovery starts the following year.
27-09
NBB filing
Annual accounts filed
fiscal year 2018 · full schema · 58 days late
2018
29-08
NBB filing
Annual accounts filed
fiscal year 2017 · full schema · 29 days late
2017
13-07
NBB filing
Annual accounts filed
fiscal year 2016 · full schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
5 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Aubel · 1 establishment unit since 1990
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Place Nicolaï 94880 AubelGround area
174 m²
Building footprint
124 m²
Volume, LiDAR
1,219 m³
Parcel 63003B0564/00E000, Wallonia · tallest building 11.4 m, ±3 floors. Linked by address, not a title deed.
1 establishment unit
Place Nicolaï 9, 4880 Aubel
since 19902.046.471.356
1 parcel
Wallonia
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 63003B0564/00E000 | Wallonia | 174 m² | 1 · 124 m² | 11.4 m · 3 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Recognitions · licences · registrations
Food safety, FASFC
1 siteAubel2.046.471.356
Similar companies · same sector, comparable size
LE LUMEÇON
BE 0563.534.762
Brussel · Eq €111k
Sevens Elise
BE 0789.573.763
Wetteren · Eq €111k
APOTHEEK TEMPELHOF
BE 0464.032.162
Leuven · Eq €111k
Pharmacie Van Leeuw Maréchal
BE 0809.888.533
Bassenge · Eq €110k
VAN DE PLAS PHARMA
BE 0437.942.825
Sint-Genesius-Rode · Eq €111k
Of 5,224 companies in sector 47730 we hold annual accounts for 3,863. 3,455 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPublic limited company
Founded11-12-1989
Fiscal year end31-12
Activities, NACEBEL
47730Retail sale of pharmaceutical products
52310
Sources
Crossroads Bank for EnterprisesNational Bank · 36 filingsAddress and cadastre registers
Data from official sources, last processed on 18-09-2026. Scores and ratios are computed by Checked and are not a credit decision.